Valeant Tells Regulators Allergan is Misleading Investors

Valeant Tells Regulators Allergan is Misleading Investors

Valeant Pharmaceuticals International Inc. said Monday it has contacted U.S. and Canadian regulators saying Allergan Inc., the Botox maker and target of it and activist investor Bill Ackman's $53 billion takeover, was trying to mislead investors over ...read more

  • Tags: